BPA
ZOM

Beacon Pointe Advisors’s Zomedica Corp. ZOM Stock Holding History

Beacon Pointe Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-81,911
Closed -$17K – 1122
2022
Q3 		$17K Buy
+81,911
New +$21.7K ﹤0.01% 991

Other funds holding ZOM

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Beacon Pointe Advisors's ZOM Position: Q4 2022 in Review

Beacon Pointe Advisors sold out of Zomedica Corp. (ZOM) in Q4 2022, closing a stake of 81,911 shares — an estimated $17K sold.

Beacon Pointe Advisors first reported a position in ZOM in Q3 2022 and held it in 1 quarter. The position peaked at $17K in Q3 2022. 91 funds tracked by Wall St. Rank hold ZOM as of Q4 2022.

  • Beacon Pointe Advisors reported no remaining Zomedica Corp. position as of Q4 2022 after selling out during the quarter.
  • Beacon Pointe Advisors sold 81,911 Zomedica Corp. shares in Q4 2022, an estimated $17K.
  • Beacon Pointe Advisors first reported a position in Zomedica Corp. in Q3 2022 and held it in 1 quarter.
  • Beacon Pointe Advisors's Zomedica Corp. position peaked at $17K in Q3 2022.
  • 91 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2022.

Based on Beacon Pointe Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.